Immutable evidence record · ticker
Liminatus Pharma, Inc. Class A Common Stock (LIMN)
Published as observed on 21 August 2026 at 14:09 BST.
Liminatus Pharma, Inc. Class A Common Stock has a balanced company news read. Its latest completed weekly trend is negative.
- As of
- 21 Aug 2026, 14:09
- Scope
- company and instrument
- Evidence
- 22 items
- Independent sources
- 2
- Country
- United States
- Sector
- Healthcare
- Previous read
- 50.000
- Change
- —
Verification
Evidence & related research
Company chart →Technicals & Market Dynamics →Technical Research Pack →Company news sentiment →Current financial news →
This is dated market research. Coverage may be delayed, incomplete or unavailable.
Cite this record:
Sharemaestro, Liminatus Pharma, Inc. Class A Common Stock (LIMN), 2026-08-21, https://sharemaestro.com/evidence/65cc86ad-d4e6-4277-9007-c075604820bd/
Record checksum 6d25d39dc842803ef57622f1de36e6e7d8e1e2ad2e477458f259e7b896846e47
